Cargando…
Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369128/ https://www.ncbi.nlm.nih.gov/pubmed/32666371 http://dx.doi.org/10.1007/s10735-020-09894-5 |
_version_ | 1783560732633202688 |
---|---|
author | Gong, Xuelian Li, Wei Dong, Lin Qu, Fangfei |
author_facet | Gong, Xuelian Li, Wei Dong, Lin Qu, Fangfei |
author_sort | Gong, Xuelian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7369128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-73691282020-07-22 Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway Gong, Xuelian Li, Wei Dong, Lin Qu, Fangfei J Mol Histol Correction Springer Netherlands 2020-07-14 2020 /pmc/articles/PMC7369128/ /pubmed/32666371 http://dx.doi.org/10.1007/s10735-020-09894-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correction Gong, Xuelian Li, Wei Dong, Lin Qu, Fangfei Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway |
title | Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway |
title_full | Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway |
title_fullStr | Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway |
title_full_unstemmed | Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway |
title_short | Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway |
title_sort | correction to: circubap2 promotes sema6d expression to enhance the cisplatin resistance in osteosarcoma through sponging mir-506-3p by activating wnt/β-catenin signaling pathway |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369128/ https://www.ncbi.nlm.nih.gov/pubmed/32666371 http://dx.doi.org/10.1007/s10735-020-09894-5 |
work_keys_str_mv | AT gongxuelian correctiontocircubap2promotessema6dexpressiontoenhancethecisplatinresistanceinosteosarcomathroughspongingmir5063pbyactivatingwntbcateninsignalingpathway AT liwei correctiontocircubap2promotessema6dexpressiontoenhancethecisplatinresistanceinosteosarcomathroughspongingmir5063pbyactivatingwntbcateninsignalingpathway AT donglin correctiontocircubap2promotessema6dexpressiontoenhancethecisplatinresistanceinosteosarcomathroughspongingmir5063pbyactivatingwntbcateninsignalingpathway AT qufangfei correctiontocircubap2promotessema6dexpressiontoenhancethecisplatinresistanceinosteosarcomathroughspongingmir5063pbyactivatingwntbcateninsignalingpathway |